ISRCTN16922410已完成未知
Does knowledge of liver fibrosis affect high-risk drinking behaviour (KLIFAD): a feasibility randomised controlled trial
ottinghamshire Healthcare NHS Foundation Trust0 个研究点目标入组 184 人开始时间: 2021年1月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 184
研究概览
简要总结
2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34732502/ (added 05/11/2021) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37448808/ (added 17/07/2023) 2023 Other publications in https://pubmed.ncbi.nlm.nih.gov/37792440/ Intervention development (added 05/10/2023)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Work package 1 (WP1):
- •1. A person aged 18 years and over attending with a primary problem of alcohol misuse as defined by initial clinical assessment and had a fibroscan in past
- •2. Willing to participate in a focus group
- •Work package 2 (WP2):
- •1. A person aged 18 years and over attending with a primary problem of alcohol misuse as defined by initial clinical assessment.
- •2. A person who previously had a fibroscan
- •3. A person with lived experience of alcohol problems, willing to consent to the recording and public use of video recording (identified via KLIFAD PPI group, existing NRN networks or research networks at Nottingham University Hospital)
- •Participants from WP1 will also be invited to participate in WP2
- •Randomised feasibility trial (WP3):
- •1. A person aged 18 years and over attending with a primary problem of alcohol misuse as defined by initial clinical assessment
排除标准
- •Work package 1 (WP1):
- •1. Other primary substance misuses even where alcohol is a factor
- •2. Lacks the capacity to give confirmed consent
- •Work package 2 (WP2):
- •1. Lacks the capacity to give confirmed consent
- •Randomised feasibility trial (WP3):
- •1. Other primary substance misuses even where alcohol is a factor
- •2. Referrals from driving offences and student referrals as these individuals are essentially not self-presenting, may have different motivation and have lower overall levels of alcohol use and so are substantially lower risk of having liver disease
- •3. Out of area clients at Edwin house in whom we cannot obtain follow up data due to lack of follow up availability
- •4. Participants unable to comply with study procedures
- •5. Lacks the capacity to give confirmed consent
研究者
相似试验
已完成
不适用
Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis BHepatic SteatosisChronic Hepatitis bHepatic FibrosisNCT05871749So Yeon Kim120
已完成
不适用
iFT: Liver fibrosis after low-energy treatment in steatohepatitisISRCTN12900952niversity of Oxford16
Enrolling By Invitation
不适用
Risk Factors for Advanced Fibrosis Among FLD PatientsNAFLDDiabetes Mellitus, Type 2Liver CirrhosisNCT05971082Helsinki University Central Hospital1,000
招募中
不适用
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver DiseaseNon-Alcoholic Fatty Liver DiseaseNCT03635541Beijing Friendship Hospital500
招募中
不适用
Biomarkers in the Diagnosis and Prognosis of NAFLDNAFLDLiver FibrosisObesityDiabetes Mellitus, Type 2NCT06098417University of Trieste500
